Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on June 18, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NavDX Testing Services

Closed
HT941025N0108Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511
New
Federal
Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334)
Solicitation # 36C24227Q0069
The Department of Veterans Affairs VISN 2 Network Contracting Office intends to award a firm fixed-price contract for STAT laboratory testing services at the Syracuse VA Medical Center. The proposed contract structure includes a base period followed by four option periods. The government intends to sole source this requirement to University Pathologists Laboratories under FAR 6.302-1(a)(2), though this special notice serves as market research to identify other capable providers, including various small business socioeconomic categories. The scope of work involves the 24/7, 365-day-a-year analysis, monitoring, and reporting of clinical and surgical specimens, utilizing advanced methods such as electron microscopy and molecular studies. Key operational requirements include picking up specimens within 30 minutes of a request and delivering final written reports within five working days. Critical results require immediate notification to authorized providers. To be eligible, the contractor must employ board-certified pathologists and accredited technologists and maintain mandatory certifications, including a NYS Department of Health Clinical Laboratory Permit, a CLIA license, and CAP or Joint Commission accreditation. This acquisition falls under NAICS code 621511. Interested parties must provide documentation of their technical expertise and socioeconomic status to the contracting officer within 10 calendar days of the notice publication.
242-NETWORK Contract Office 02 (36C242)

POSTED

about 20 hours ago

DEADLINE

in 9 days
NAICS: 621511
New
SLED
Controlled Substances and Alcohol Use Testing
Solicitation # DOT-RFP-27-9020-JM
The Florida Department of Transportation is soliciting competitive proposals under solicitation number DOT-RFP-27-9020-JM for third-party controlled substances and alcohol use testing program management services. The selected vendor will be responsible for administering testing for CDL drivers and other department employees, including random selection and testing using scientifically valid methods, providing Substance Abuse Professional services for rehabilitation monitoring, and maintaining 24-hour emergency collection coordination. The scope of work requires strict adherence to federal regulations, including USDOT 49 CFR Part 40 and FMCSA 49 CFR Part 382, as well as the Florida Drug-Free Workplace Act. Deliverables include a secure, password-protected website for results and statistical reporting, with monthly itemized invoicing submitted through the MyFloridaMarketplace system. The procurement process requires a two-part submission consisting of a technical proposal and a price proposal. To be considered responsive, proposers must achieve a minimum average score of 70 points on the technical evaluation, which is weighted across a management plan, work plan, executive summary, and technical plan. The contract is planned for performance across multiple fiscal years from 2027 through 2031. Eligible bidders must be registered in MyFloridaMarketplace, authorized to do business in Florida, and compliant with scrutinized companies lists and non-discrimination statutes. Evaluation is based on the grand total of tests, fees, and services, and the department reserves the right to conduct on-site reviews of facilities and qualifications prior to contract execution.
Florida Department of Transportation

POSTED

1 day ago

DEADLINE

in 14 days
NAICS: 621511
New
Federal
Q501--STAT CLINICAL LAB TESTING AND AUTOPSIES
Solicitation # 36C24627Q0076
The Department of Veterans Affairs, Network Contracting Office 6, is conducting market research through a Sources Sought Notice to identify qualified businesses capable of providing comprehensive referral laboratory testing, specimen transportation, and autopsy services. The primary service area includes the Hunter Holmes McGuire VA Medical Center and associated Central Virginia VA Health Care System locations. The scope of work encompasses clinical and anatomic pathology requirements, including analytical testing, the processing and maintenance of specimen integrity, STAT testing, and medical autopsy services involving gross and microscopic examinations. The contractor will also be responsible for providing secure specimen transportation, consultative services for test selection and interpretation, and electronic access to patient results. This opportunity is open to various small business concerns, including SDVOSBs, VOSBs, 8(a), HUBZone, WOSB, and EDWOSB entities, under NAICS code 621511 with a size standard of 45.5 million dollars. Providers must maintain strict compliance with HIPAA regulations and hold essential certifications, such as CLIA and CMS-deemed status through organizations like the College of American Pathologists or The Joint Commission. Interested parties must submit a capability statement not exceeding five pages to Gordon Burns by October 27, 2026, at 1:00 p.m. ET. This notice is for acquisition planning purposes only and does not constitute a formal solicitation or a guarantee of a future contract award.
246-NETWORK Contracting Office 6 (36C246)

POSTED

2 days ago

DEADLINE

in 6 days
NAICS: 621511
New
Federal
6640--KARIUS TEST
Solicitation # 36C24827Q0069
The Department of Veterans Affairs, through Network Contracting Office 8 for the VA Caribbean Healthcare System in San Juan, Puerto Rico, has issued a Sources Sought Notice under solicitation number 36C24827Q0069. This notice is for market research purposes to identify qualified businesses capable of providing the Karius Next-Generation Sequencing (NGS) Infectious Disease Test, a cell-free DNA diagnostic tool used to identify infectious microorganisms in the blood. The government is specifically looking for providers under NAICS code 621511 for Medical Laboratories, which has a size standard of 41.5 million dollars. The required scope of work includes providing all necessary transport supplies such as lab test request forms, shipping containers with required preservatives, and tracking air bills to ensure specimen integrity. The contractor must also provide a communication method for VACHS laboratories to inquire about pending tests and deliver secure electronic test results and reports within established timeframes. Interested parties must be registered in the System for Award Management and submit a qualifications letter including company details, UEI, socio-economic category, a technical capability statement, and evidence of past performance. Responses must be emailed to Contract Specialist Eunice Bones by 1:00 PM EST on October 23, 2026, with the subject line RFI# 36C24827Q0069 - Karius Test.
248-NETWORK Contract Office 8 (36C248)

POSTED

2 days ago

DEADLINE

in 2 days

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity, Healthcare Contracting Division - West in San Diego, intends to award a firm-fixed-price, sole source service contract to Naveris Inc. The purpose of this contract is to provide all necessary personnel, equipment, supplies, transportation, and related non-personal services to perform NavDX testing for the Naval Medical Center San Diego. This procurement will be executed under the authority of Federal Acquisition Regulation 13.106-1(b)(1), which allows for sole source contracts when only one vendor is available to meet the government’s needs. Naveris Inc, located in Waltham, Massachusetts, has been identified as the only capable provider for the specialized NavDX laboratory testing services required. The contract is structured with a base year beginning July 1, 2025, and includes four additional option years, concluding on June 30, 2030. The services fall under NAICS code 621555 (Medical Laboratories), with a business size standard of $41.5 million, and are classified under Product Service Code Q301 (Reference Laboratory Testing). While this notice is not a solicitation for competitive proposals, interested vendors may submit capability statements by June 24, 2025, for consideration. All responses must provide comprehensive technical and management data to clearly demonstrate the provider's ability to fulfill the contract requirements. The final decision on whether to proceed with a sole source award or competitive procurement remains at the government’s discretion. For more information, interested parties are directed to contact the designated Contract Specialist via email, as telephone inquiries will not be accepted.

General Info

Sole source firm-fixed-price contract to Naveris Inc. for NavDX testing at Naval Medical Center.

NAICS

621511 - Medical Laboratories

Place of Performance

San Diego, CA, USA

Set-Aside

NONE

Documents

1

HT941025N0108 - Notice of Intent to Sole Source NavDX Testing

PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DEFENSE HEALTH AGENCY (DHA)
Contacts2 people available
OfficeFALLS CHURCH, VA, 22042, USA
Office AddressFALLS CHURCH, VA, 22042, USA
Contacts
Danielle M Zulfer

Full Description

Show more

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SERVICE CONTRACT


AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.  The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West, San Diego, intends to negotiate and award a firm-fixed-price contract to Naveris Inc to provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform NavDX testing for Naval Medical Center San Diego (NMCSD), in accordance with the Federal Acquisition Regulation (FAR) 13.106-1(b)(1), only one source being available to meet the Government’s needs, to:


Naveris Inc


21 Hickory Dr Ste 600


Waltham, MA 02451-1034


The North American Industry Classification System (NAICS) code for this requirement is 621555 – Medical Laboratories; the business size standard is $41.5 million. 


The Product Service Code (PSC) is Q301 - Reference Laboratory Testing.


The objective of this sole source award is to purchase all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform NavDX testing for NMCSD.


CLIN 0001


NavDX Testing Services


CLIN 1001


NavDX Testing Services


CLIN 2001


NavDX Testing Services


CLIN 3001


NavDX Testing Services


CLIN 4001


NavDX Testing Services


Period of Performance:


01 July 2025 – 30 June 2030 (Base + Four Option Years)


This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement.  Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required service for NMCSD.  Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point.  All capability statements received by the due date of this notice will be considered by the Government.  A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response.  A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.  Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.


If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to the Contract Specialist, Danielle M Zulfer at: danielle.m.zulfer.civ@health.mil


The closing date for challenges is no later than 1600 Pacific Standard Time on June 24, 2025.


NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

More opportunities from Department Of Defense → DEFENSE HEALTH AGENCY (DHA)

Same awarding agency

NAICS: 325412
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9404
The Defense Health Agency, acting for the Department of War, is soliciting quotes under solicitation HT9402-26-Q-9404 to establish Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program agreements. This procurement is mandated by 10 U.S.C. 1074g to create an integrated pharmacy benefits program for the Military Health System, covering Military Treatment Facilities, the TRICARE Mail Order Pharmacy, and the Basic Core Formulary. The Pharmacy and Therapeutics Committee will evaluate pharmaceutical agents based on relative clinical effectiveness and cost effectiveness to determine their placement on the Uniform Formulary. Specifically, the November 2026 review includes twelve newly approved drugs across various classes, including oncological agents, antifungals, and insulins. Interested manufacturers must submit quotes by October 26, 2026, and provide detailed clinical data regarding the advantages and therapeutic placement of their drugs. Key requirements include maintaining active SAM.gov registration, ensuring Trade Agreements Act compliance via FAR 52.225-6, and agreeing to utilize the Department of War Prime Vendor Program for distribution. The agreement also requires opening limited distribution channels to Accred for mail order services. Award decisions are based on the combined evaluation of clinical and cost effectiveness, with the TRICARE retail network utilization accrual beginning upon the Contracting Officer's signature. The contract allows for termination by either party with 120 days written notice.
Pharmaceutical Preparation Manufacturing

POSTED

13 days ago

DEADLINE

in 5 days
View Details
NAICS: 541715
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

21 days ago

DEADLINE

N/A
View Details
NAICS: 561910
Federal
DHA - Offsite Sterile Processing Support Services
Solicitation # HT9427-27-RFI-0001
The Defense Health Agency (DHA) is issuing a Request for Information (RFI) to identify qualified contractors capable of providing offsite Sterile Processing (SP) support for various Military Treatment Facilities (MTFs) across eight DHA networks. This initiative is part of a Business Case Analysis to improve service resilience and workload stability, ensuring that surgical capabilities are not halted by onsite equipment failures. The scope of work involves the transportation of surgical instruments between MTFs and contractor-owned offsite facilities, where the contractor will provide the necessary personnel, equipment, and facilities to perform decontamination, assembly, sterilization, inventory verification, and quality control. The equipment to be processed includes specialized items such as minimally invasive surgical cases, Da Vinci accessories, and power equipment, with an estimated volume of approximately 2,000 trays monthly per participating MTF. This RFI is strictly for market research and planning purposes and does not constitute a formal solicitation or an obligation to award a contract. The DHA is seeking capability statements from healthcare companies and hospitals that detail their experience with similar projects over the last five years and their proposed implementation strategy. Responses must be submitted in PDF format to the designated Contract Specialist by 11:00 AM EDT on October 30, 2026, and are limited to 10 pages using a 12-point font. The government has not yet determined if a small business set-aside is appropriate and will use the information gathered from these responses to make that decision.
Packaging and Labeling Services

POSTED

22 days ago

DEADLINE

in 9 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS